expert roundtables

Individualizing Treatment for Patients With Multiple Myeloma Based on Disease Stage and Risk
Oncology

Individualizing Treatment for Patients With Multiple Myeloma Based on Disease Stage and Risk

expert roundtables
By Carol Ann Huff, MD; James R. Berenson, MD; Paul G. Richardson, MD
Oncology

Treatment of Relapsed Mantle Cell Lymphoma Following Extended Response to Prior Therapy

expert roundtables
By Brad Kahl, MD; Julie M. Vose, MD, MBA, FASCO; Thomas J. Kipps, MD, PhD
Recommendations for Appropriate Use of Autologous Stem Cell Transplantation in a First-line Regimen for Mantle Cell Lymphoma
Oncology

Recommendations for Appropriate Use of Autologous Stem Cell Transplantation in a First-line Regimen for Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Julie M. Vose, MD, MBA, FASCO; Thomas J. Kipps, MD, PhD
Myeloproliferative Neoplasms: Risk Stratification and Response Evaluation
Oncology

Myeloproliferative Neoplasms: Risk Stratification and Response Evaluation

expert roundtables
By Katherine Walsh, MD, FACP; Rami S. Komrokji, MD; Ruben A. Mesa, MD, FACP
Polycythemia Vera: Factors That May Warrant a Change in Cytoreductive Therapy
Oncology

Polycythemia Vera: Factors That May Warrant a Change in Cytoreductive Therapy

expert roundtables
By Katherine Walsh, MD, FACP; Rami S. Komrokji, MD; Ruben A. Mesa, MD, FACP
Load More